Latest News for TITMF
Rocket Pharmaceuticals (NASDAQ:RCKT) announced that the US Food and Drug Administration (FDA) has granted accelerated approval for KRESLADI (marnetegragene...
Titomic Ltd (ASX:TTT, OTC:TITMF, FRA:T04) has secured a EUR1.02 million (about A$1.71 million) purchase order from Royal NLR, the Netherlands’ national...
Bank of America upgraded Acadia Pharmaceuticals (NASDAQ:ACAD) to 'Buy' from 'Neutral', arguing that a recent pullback in the stock has created a more...
UBS analysts maintained a ‘Buy’ rating on Microsoft Corp (NASDAQ:MSFT), while lowering their 12-month price target to $510 from $600, citing investor...
Atlassian (NASDAQ:TEAM) has announced plans to cut roughly 10% of its workforce, or about 1,600 jobs, as part of a restructuring aimed at increasing...
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for TITMF.
Senate Trading
No Senate trades found for TITMF.
U.S. House Trading
No House trades found for TITMF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.